Methylphenidate efficacy: Immediate versus extended release at short term in mexican children with ADHD assessed by conners scale and EEG

Neurology Research International

Volumn 2015, Issue , 2015, Pages

  Durand Rivera, Alfredo ^a,b   Alatorre Miguel, Efren ^a   Zambrano Sánchez, Elizabeth ^a   Reyes Legorreta, Celia ^a  

^a INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

^b Centro de Atención Médica y Educación Especial   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

IMMEDIATE RELEASE METHYLPHENIDATE; LONG ACTING DRUG; LONG ACTING METHYLPHENIDATE; METHYLPHENIDATE; UNCLASSIFIED DRUG;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RELEASE; DSM-IV; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPH; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERACTIVITY; MALE; MAXIMUM PLASMA CONCENTRATION; MENTAL INSTABILITY; MEXICAN; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PSYCHOSOMATICS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SYMPTOMATOLOGY;

EID: 84925726146     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2015/207801     Document Type: Article

References (27)

1. G. Polanczyk, M. S. de Lima, B. L. Horta, J. Biederman, and L. A. Rohde, "Te worldwide prevalence of ADHD: a systematic review and metaregression analysis," The American Journal of Psychiatry, vol. 164, no. 6, pp. 942-948, 2007.
2. M. Döpfner, A. Görtz-Dorten, D. Breuer, and A. Rothen-berger, "An observational study of once-daily modifed-release methylphenidate in ADHD: efectiveness on symptoms and impairment, and safety," European Child and Adolescent Psychiatry, vol. 20, supplement 2, pp. S243-S255, 2011.
3. J. Lee, N. Grizenko, V. Bhat, S. Sengupta, A. Polotskaia, and R. Joober, "Relation between therapeutic response and side efects induced by methylphenidate as observed by parents and teachers of children with ADHD," BMC Psychiatry, vol. 11, article 70, 2011.
4. J. Biederman and S. V. Faraone, "Attention-defcit hyperactivity disorder," The Lancet, vol. 366, no. 9481, pp. 237-248, 2005.
5. L. E. Cutting, C. W. Koth, E. M. Mahone, and M. B. Denckla, "Evidence for unexpected weaknesses in learning in children with attention-defcit/hyperactivity disorder without reading disabilities," Journal of Learning Disabilities, vol. 36, no. 3, pp. 259-269, 2003.
6. G. J. DuPaul, K. E. McGoey, T. L. Eckert, and J. VanBrakle, "Preschool children with attention-defcit/hyperactivity disorder: impairments in behavioral, social, and school functioning," Journal of the American Academy of Child and Adolescent Psychiatry, vol. 40, no. 5, pp. 508-515, 2001.
7. American Psychiatric Association, "Attention-defcit and disruptive behavior disorders. Attention-defcit/hyperactivity disorder," in Diagnostic and Statistical Manual of Mental Disorders, pp. 85-103, American Psychiatric Association, Arlington, Va, USA, 4th edition, 2000.
8. I. Takon, "Clinical use of a modifed release methylphenidate in the treatment of childhood attention defcit hyperactivity disorder," Annals of General Psychiatry, vol. 10, article 25, 2011.
9. J. Biederman, E. Mick, S. V. Faraone et al., "Infuence of gender on attention defcit hyperactivity disorder in children referred to a psychiatric clinic," American Journal of Psychiatry, vol. 159, no. 1, pp. 36-42, 2002.
10. S. V. Faraone and S. A. Khan, "Candidate gene studies of attention-defcit/hyperactivity disorder," Journal of Clinical Psychiatry, vol. 67, supplement 8, pp. 13-20, 2006.
11. T. D. Banerjee, F. Middleton, and S. V. Faraone, "Environmental risk factors for attention-defcit hyperactivity disorder," Acta Paediatrica, vol. 96, no. 9, pp. 1269-1274, 2007.
12. V. R. Anderson and G. M. Keating, "Methylphenidate con-trolleddelivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attentiondefcit hyperactivity disorder," Pediatric Drugs, vol. 8, no. 5, pp. 319-333, 2006.
13. R. A. Barkley, T. L. Shelton, C. Crosswait et al., "Preschool children with disruptive behavior: three-year outcome as a function of adaptive disability," Development and Psychopathology, vol. 14, no. 1, pp. 45-67, 2002.
14. K. M. Patrick, "Pharmacokinetics and actions of methylphen-idate," in Psychopharmacology, the Tird Generation of Progress, H. Meltzer, Ed., pp. 1387-1395, Raven Press, NewYork, NY, USA, 1987.
15. J. H. Ferguson, "National institutes of health consensus development conference statement: diagnosis and treatment of attention-defcit/hyperactivity disorder (ADHD)," Journal of the American Academy of Child and Adolescent Psychiatry, vol. 39, no. 2, pp. 182-193, 2000.
16. M. A. González, H. S. Pentikis, N. Anderl et al., "Meth-ylphenidate bioavailability from two extended-release formulations," International Journal of Clinical Pharmacology and Terapeutics, vol. 40, no. 4, pp. 175-184, 2002.
17. W. E. Pelham, E. M. Gnagy, L. Burrows-Maclean et al., "Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings," Pediatrics, vol. 107, no. 6, article E105, 2001.
18. "Controlled drug delivery," in Drug and the Pharmaceutical Sciences, J. R. Robinson, Ed., vol. 29, chapter 1, Marcel Dekker, New York, NY, USA, 1987.
19. E. A. Michael, Ed., Pharmaceutics. The Science of Dosage Form Design, Churchill Livingstone, Elsevier, 2nd edition, 2002.
20. L. L. Greenhill, "Stimulant medication treatment of children with attention defcit hyperactivity disorder," in Attention Defcit Hyperactivity Disorder: State of Science. Best Practices, P. S. Jensen and J. R. Cooper, Eds., pp. 9-27, Civic Research Institute, Kingston, NJ, USA, 2002.
21. M. Fernando, G. Rubén, R. Patricia, C. Etchepareborda Máximo, and A. Luis, "Actualización farmacológica en el trastorno por défcit de atención/hiperactividad: modelos de intervención y nuevos fármacos," Revista de Neurologia, vol. 54, supplement 3, pp. S41-S53, 2012.
22. F. Montañés-Rada, A. B. Gangoso-Fermoso, and M. A. Martínez-Granero, "Fármacos para el trastorno por défcit de atención/hiper actividad," Revista de Neurologí a, vol. 48, no. 9, pp. 469-481, 2009.
23. C. Castañeda-Cabrero, G. Lorenzo-Sanz, E. Caro-Martínez, J. M. Gaĺan-Sánchez, J. Sáez-Á lvarez, and F. Paradinas-Jiménez, "Electroencephalographic alterations in children with attention defcit hyperactivity disorder," Revista de Neurologia, vol. 37, no. 10, pp. 904-908, 2003.
24. M. C. Etchepareborda, "Epilepsia y aprendizaje: abordaje neu-ropsicologico," Revista de Neurologia, vol. 28, supplement 2, pp. S142-S149, 1999.
25. F. Mulas, S. Hernández, L. Mattos, L. Abad-Mas, and M. C. Etchepareborda, "Difcultades del aprendizaje en los niños epiĺepticos," Revista de Neurologí a, vol. 42, supplement 2, pp. S157-S162, 2006.
26. F. Mulas, M. Tellez de Meneses, S. Hernandez-Muela, L. Mattos, and I. Pitarch, "Trastorno por defcit de atencion e hiperactivi-dad y epilepsia," Revue Neurologique, vol. 39, pp. 192-195, 2004.
27. J. O. Cornelio-Nieto, M. E. Borbolla-Sala, and A. Gallegos-Dimas, "Alteraciones electroencefalogŕafcas en ninos con trastorno por defcit de atención/hiper actividad," Revista de Neurología, vol. 52, supplement 1, pp. S97-S101, 2011.